These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30986113)

  • 1. Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management.
    Lawton J; Blackburn M; Rankin D; Werner C; Farrington C; Hovorka R; Hallowell N
    AJOB Empir Bioeth; 2019; 10(2):100-112. PubMed ID: 30986113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.
    Lawton J; Blackburn M; Rankin D; Allen JM; Campbell FM; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Elleri D; Hovorka R
    Diabetes Technol Ther; 2019 Mar; 21(3):119-127. PubMed ID: 30720338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of using a closed-loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents.
    Lawton J; Blackburn M; Rankin D; Allen J; Campbell F; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Hovorka R;
    Diabet Med; 2019 Jun; 36(6):753-760. PubMed ID: 30575114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambassadors of hope, research pioneers and agents of change-individuals' expectations and experiences of taking part in a randomised trial of an innovative health technology: longitudinal qualitative study.
    Lawton J; Blackburn M; Breckenridge JP; Hallowell N; Farrington C; Rankin D
    Trials; 2019 May; 20(1):289. PubMed ID: 31133076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's Experiences of Day-and-Night Closed-Loop Insulin Delivery During Type 1 Diabetes Pregnancy.
    Farrington C; Stewart Z; Hovorka R; Murphy H
    J Diabetes Sci Technol; 2018 Nov; 12(6):1125-1131. PubMed ID: 30288999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes.
    Hendrieckx C; Poole LA; Sharifi A; Jayawardene D; Loh MM; Horsburgh JC; Bach LA; Colman PG; Kumareswaran K; Jenkins AJ; MacIsaac RJ; Ward GM; Grosman B; Roy A; O'Neal DN; Speight J
    Diabetes Technol Ther; 2017 Jul; 19(7):410-416. PubMed ID: 28537437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health professionals' views about who would benefit from using a closed-loop system: a qualitative study.
    Lawton J; Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Randell T; Besser REJ; Trevelyan N; Hovorka R;
    Diabet Med; 2020 Jun; 37(6):1030-1037. PubMed ID: 31989684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staff experiences of closing out a clinical trial involving withdrawal of treatment: qualitative study.
    Lawton J; White D; Rankin D; Elliott J; Taylor C; Cooper C; Heller S; Hallowell N
    Trials; 2017 Feb; 18(1):61. PubMed ID: 28173843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial.
    Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Ghatak A; Randell T; Besser REJ; Trevelyan N; Hovorka R; Lawton J
    Diabetes Technol Ther; 2020 Jun; 22(6):468-475. PubMed ID: 32048877
    [No Abstract]   [Full Text] [Related]  

  • 12. Adolescents' Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study.
    Rankin D; Kimbell B; Allen JM; Besser REJ; Boughton CK; Campbell F; Elleri D; Fuchs J; Ghatak A; Randell T; Thankamony A; Trevelyan N; Wilinska ME; Hovorka R; Lawton J
    J Diabetes Sci Technol; 2021 Sep; 15(5):1042-1051. PubMed ID: 34261348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England.
    Farrington C; Hovorka R; Murphy HR
    Diabetes Technol Ther; 2020 May; 22(5):404-410. PubMed ID: 31913061
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System.
    Iturralde E; Tanenbaum ML; Hanes SJ; Suttiratana SC; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
    Diabetes Educ; 2017 Apr; 43(2):223-232. PubMed ID: 28340542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History and Perspective on DIY Closed Looping.
    Lewis D
    J Diabetes Sci Technol; 2019 Jul; 13(4):790-793. PubMed ID: 30348013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and Solutions.
    Rankin D; Hart RI; Kimbell B; Barnard-Kelly K; Brackenridge A; Byrne C; Collett C; Dover AR; Hartnell S; Hunt KF; Lee TTM; Lindsay RS; McCance DR; McKelvey A; Rayman G; Reynolds RM; Scott EM; White SL; Hovorka R; Murphy HR; Lawton J
    Diabetes Technol Ther; 2023 Apr; 25(4):260-269. PubMed ID: 36662589
    [No Abstract]   [Full Text] [Related]  

  • 20. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.